{
    "data": [
        {
            "id": "4658144",
            "type": "article",
            "attributes": {
                "publishOn": "2023-12-15T16:48:50-05:00",
                "isLockedPro": false,
                "commentCount": 29,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/948363186/image_948363186.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Risk/Reward Highly Skewed To The Upside",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "107171",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "509414",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/4658144-cvs-health-riskreward-highly-skewed-to-the-upside"
            }
        },
        {
            "id": "4656648",
            "type": "article",
            "attributes": {
                "publishOn": "2023-12-07T16:11:48-05:00",
                "isLockedPro": false,
                "commentCount": 9,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1225090614/image_1225090614.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: A Good Fit To Buffett's 10x Pretax Rule",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106207",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "507505",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4656648-cvs-health-a-good-fit-to-buffetts-10x-pretax-rule"
            }
        },
        {
            "id": "4654657",
            "type": "article",
            "attributes": {
                "publishOn": "2023-11-28T14:56:07-05:00",
                "isLockedPro": false,
                "commentCount": 52,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/624114992/image_624114992.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Play The Long Game",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "24018",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "505139",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4654657-cvs-health-play-the-long-game"
            }
        },
        {
            "id": "4654514",
            "type": "article",
            "attributes": {
                "publishOn": "2023-11-28T04:09:07-05:00",
                "isLockedPro": false,
                "commentCount": 37,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1464215902/image_1464215902.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: The Core Business Model Is In Trouble",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "36351",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "505110",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4654514-cvs-health-core-business-model-is-in-trouble"
            }
        },
        {
            "id": "4654420",
            "type": "article",
            "attributes": {
                "publishOn": "2023-11-27T17:12:12-05:00",
                "isLockedPro": false,
                "commentCount": 8,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1464215902/image_1464215902.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Not One Dividend Cut In 30 Years And A Good Upside",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105218",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "504784",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4654420-cvs-health-not-one-dividend-cut-in-30-years-and-a-good-upside"
            }
        },
        {
            "id": "4653406",
            "type": "article",
            "attributes": {
                "publishOn": "2023-11-21T10:19:34-05:00",
                "isLockedPro": false,
                "commentCount": 28,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: All Eyes On December Investor Day",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106939",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "503662",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4653406-cvs-health-all-eyes-on-december-investor-day"
            }
        },
        {
            "id": "4644117",
            "type": "article",
            "attributes": {
                "publishOn": "2023-10-26T18:23:36-04:00",
                "isLockedPro": false,
                "commentCount": 9,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1464215905/image_1464215905.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104985",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "496934",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4644117-cvs-health-ahead-of-q3-earnings-making-the-pivot-toward-value-based-care-work"
            }
        },
        {
            "id": "4642413",
            "type": "article",
            "attributes": {
                "publishOn": "2023-10-22T03:42:51-04:00",
                "isLockedPro": false,
                "commentCount": 20,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1225090614/image_1225090614.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Rite Aid's Chapter 11 Provides Opportunity",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106324",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "495464",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4642413-cvs-health-rite-aids-chapter-11-provides-opportunity"
            }
        },
        {
            "id": "4642394",
            "type": "article",
            "attributes": {
                "publishOn": "2023-10-21T23:50:29-04:00",
                "isLockedPro": false,
                "commentCount": 11,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: A Bargain Long-Term Opportunity",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "70365",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "490469",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4642394-cvs-health-stock-bargain-long-term-opportunity"
            }
        },
        {
            "id": "4642225",
            "type": "article",
            "attributes": {
                "publishOn": "2023-10-20T14:58:40-04:00",
                "isLockedPro": false,
                "commentCount": 4,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Presents Technical Strength Amidst Robust Financials",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106871",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "495055",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4642225-cvs-health-presents-technical-strength-amidst-robust-financials"
            }
        },
        {
            "id": "4642113",
            "type": "article",
            "attributes": {
                "publishOn": "2023-10-20T09:00:00-04:00",
                "isLockedPro": false,
                "commentCount": 6,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1414279526/image_1414279526.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS: Get Paid 3.43%, Before M&A Synergy Materializes By 2026",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106485",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "494820",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4642113-cvs-stock-get-paid-3-43-percent-before-m-and-a-synergy-materializes-by-2026"
            }
        },
        {
            "id": "4642095",
            "type": "article",
            "attributes": {
                "publishOn": "2023-10-20T06:57:48-04:00",
                "isLockedPro": false,
                "commentCount": 12,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1411999106/image_1411999106.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: 'Only' A Fair Company For A Wonderful Price?",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "102404",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "494775",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4642095-cvs-health-only-a-fair-company-for-a-wonderful-price"
            }
        },
        {
            "id": "4639083",
            "type": "article",
            "attributes": {
                "publishOn": "2023-10-05T02:10:37-04:00",
                "isLockedPro": false,
                "commentCount": 26,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Offers Recession-Resistant Growth With Transformation",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106554",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "490956",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4639083-cvs-health-stock-offers-recession-resistant-growth-transformation-buy"
            }
        },
        {
            "id": "4635958",
            "type": "article",
            "attributes": {
                "publishOn": "2023-09-19T04:12:06-04:00",
                "isLockedPro": false,
                "commentCount": 10,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1212846677/image_1212846677.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "The Top 3 Reasons To Buy CVS Health",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106271",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "486617",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4635958-cvs-health-stock-top-3-reasons-buy"
            }
        },
        {
            "id": "4635955",
            "type": "article",
            "attributes": {
                "publishOn": "2023-09-19T03:48:28-04:00",
                "isLockedPro": false,
                "commentCount": 4,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1472256397/image_1472256397.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Is Undervalued If We Avoid Recession",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "107102",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "486653",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4635955-cvs-health-is-undervalued-if-we-avoid-recession"
            }
        },
        {
            "id": "4635884",
            "type": "article",
            "attributes": {
                "publishOn": "2023-09-18T17:00:27-04:00",
                "isLockedPro": false,
                "commentCount": 3,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1464215902/image_1464215902.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Weighing High Free Cash Flow And Bearish Price Trends",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106553",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "486634",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4635884-cvs-health-weighing-high-free-cash-flow-and-bearish-price-trends"
            }
        },
        {
            "id": "4635852",
            "type": "article",
            "attributes": {
                "publishOn": "2023-09-18T15:13:36-04:00",
                "isLockedPro": false,
                "commentCount": 5,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Stock: The Risk-Reward Is In A Better Place",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105843",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "486609",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4635852-cvs-stock-the-risk-reward-is-in-a-better-place"
            }
        },
        {
            "id": "4631100",
            "type": "article",
            "attributes": {
                "publishOn": "2023-08-25T09:17:43-04:00",
                "isLockedPro": false,
                "commentCount": 70,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Share Price Suffers As Business Transformation Flounders",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104985",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "480953",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4631100-cvs-health-share-price-suffers-as-business-transformation-flounders"
            }
        },
        {
            "id": "4629646",
            "type": "article",
            "attributes": {
                "publishOn": "2023-08-18T15:21:26-04:00",
                "isLockedPro": false,
                "commentCount": 38,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1456713262/image_1456713262.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Blue Shield Runs To Amazon, But Valuation Still Makes Sense",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "103219",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "479346",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4629646-cvs-health-blue-shield-runs-to-amazon-but-valuation-still-makes-sense"
            }
        },
        {
            "id": "4628974",
            "type": "article",
            "attributes": {
                "publishOn": "2023-08-16T12:51:09-04:00",
                "isLockedPro": false,
                "commentCount": 91,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/471569977/image_471569977.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106207",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "475510",
                            "type": "sentiment"
                        },
                        {
                            "id": "475511",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4628974-walgreens-vs-cvs-i-call-a-tie-now-based-on-a-peter-lynch-evaluation"
            }
        },
        {
            "id": "4625305",
            "type": "article",
            "attributes": {
                "publishOn": "2023-08-08T10:00:26-04:00",
                "isLockedPro": false,
                "commentCount": 52,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1402430797/image_1402430797.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS: In Search Of A Major Low",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "53262",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "476600",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4625305-cvs-in-search-of-a-major-low"
            }
        },
        {
            "id": "4623253",
            "type": "article",
            "attributes": {
                "publishOn": "2023-08-03T11:08:50-04:00",
                "isLockedPro": false,
                "commentCount": 31,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413674588/image_1413674588.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Second Quarter Was Only Decent, But Integration Is On Track",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106939",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "475475",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4623253-cvs-health-second-quarter-was-only-decent-but-integration-is-on-track"
            }
        },
        {
            "id": "4618766",
            "type": "article",
            "attributes": {
                "publishOn": "2023-07-21T11:24:32-04:00",
                "isLockedPro": false,
                "commentCount": 42,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1460074412/image_1460074412.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Undervalued Long-Term Gem",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "107096",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "470273",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4618766-cvs-health-undervalued-long-term-gem"
            }
        },
        {
            "id": "4617470",
            "type": "article",
            "attributes": {
                "publishOn": "2023-07-17T06:14:20-04:00",
                "isLockedPro": false,
                "commentCount": 17,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1222334096/image_1222334096.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: A Portfolio Must Have",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106202",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "470844",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4617470-cvs-health-stock-portfolio-must-have"
            }
        },
        {
            "id": "4616805",
            "type": "article",
            "attributes": {
                "publishOn": "2023-07-13T08:05:00-04:00",
                "isLockedPro": false,
                "commentCount": 14,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1257405518/image_1257405518.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Buy The Complexity Discount",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105703",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "470272",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4616805-cvs-health-stock-buy-complexity-discount"
            }
        },
        {
            "id": "4614520",
            "type": "article",
            "attributes": {
                "publishOn": "2023-07-01T14:00:00-04:00",
                "isLockedPro": false,
                "commentCount": 39,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1162414869/image_1162414869.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Improved Upside And Yield After The Steep Sell-Off",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106485",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "467139",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4614520-cvs-stock-improved-upside-yield-after-steep-sell-off-reiterate-buy"
            }
        },
        {
            "id": "4612435",
            "type": "article",
            "attributes": {
                "publishOn": "2023-06-20T05:10:50-04:00",
                "isLockedPro": false,
                "commentCount": 32,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1456713262/image_1456713262.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health's Valuation Downtrend - Inflection Point Unclear",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104985",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "464740",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4612435-cvs-health-valuation-downtrend-inflection-point-unclear"
            }
        },
        {
            "id": "4612017",
            "type": "article",
            "attributes": {
                "publishOn": "2023-06-16T15:13:32-04:00",
                "isLockedPro": false,
                "commentCount": 28,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/539440938/image_539440938.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Examining The Implications Of Higher Medical Costs",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106939",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "464130",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4612017-cvs-health-examining-the-implications-of-higher-medical-costs"
            }
        },
        {
            "id": "4612001",
            "type": "article",
            "attributes": {
                "publishOn": "2023-06-16T13:25:20-04:00",
                "isLockedPro": false,
                "commentCount": 22,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Buy The Dip!",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "102404",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "464057",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4612001-cvs-health-buy-the-dip"
            }
        },
        {
            "id": "4611769",
            "type": "article",
            "attributes": {
                "publishOn": "2023-06-15T13:17:52-04:00",
                "isLockedPro": false,
                "commentCount": 61,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1435303542/image_1435303542.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Buy The Panic",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "68315",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "463820",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4611769-cvs-health-buy-the-panic"
            }
        },
        {
            "id": "4611756",
            "type": "article",
            "attributes": {
                "publishOn": "2023-06-15T12:28:51-04:00",
                "isLockedPro": false,
                "commentCount": 20,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1456713262/image_1456713262.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: More Earnings Downgrades Coming But Stock Reaching Compelling Valuation",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "103219",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "463798",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4611756-cvs-health-more-earnings-downgrades-coming-but-stock-reaching-compelling-valuation"
            }
        },
        {
            "id": "4606402",
            "type": "article",
            "attributes": {
                "publishOn": "2023-05-22T04:52:22-04:00",
                "isLockedPro": false,
                "commentCount": 100,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455245507/image_1455245507.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: A Gem Among Dividend Companies",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106297",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "457802",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4606402-cvs-health-stock-gem-among-dividend-companies"
            }
        },
        {
            "id": "4604938",
            "type": "article",
            "attributes": {
                "publishOn": "2023-05-16T05:22:29-04:00",
                "isLockedPro": false,
                "commentCount": 103,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/948363186/image_948363186.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Margins, Margins, Margins",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "103890",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "456457",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/4604938-cvs-health-investors-should-look-margin-stock-buy"
            }
        },
        {
            "id": "4603707",
            "type": "article",
            "attributes": {
                "publishOn": "2023-05-12T13:41:59-04:00",
                "isLockedPro": false,
                "commentCount": 49,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1464215902/image_1464215902.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS: A High Cash Flow Yield, But A Low Return On Capital",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106980",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "455753",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4603707-cvs-a-high-cash-flow-yield-but-a-low-return-on-capital"
            }
        },
        {
            "id": "4602430",
            "type": "article",
            "attributes": {
                "publishOn": "2023-05-10T07:45:24-04:00",
                "isLockedPro": false,
                "commentCount": 125,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1269594016/image_1269594016.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Investors Getting A Bellyache",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "24018",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "455180",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4602430-cvs-health-investors-getting-bellyache"
            }
        },
        {
            "id": "4599492",
            "type": "article",
            "attributes": {
                "publishOn": "2023-05-03T15:07:37-04:00",
                "isLockedPro": false,
                "commentCount": 91,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/53139961/image_53139961.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Explaining The Guidance Cut And How To Evaluate It After Q1 Earnings Beat",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106939",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "453890",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/4599492-cvs-explaining-guidance-cut-how-to-evaluate-q1-earnings-beat"
            }
        },
        {
            "id": "4599354",
            "type": "article",
            "attributes": {
                "publishOn": "2023-05-03T10:30:17-04:00",
                "isLockedPro": false,
                "commentCount": 39,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1225090614/image_1225090614.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Stock: Too Cheap To Ignore",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "68315",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "453818",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4599354-cvs-health-stock-too-cheap-to-ignore"
            }
        },
        {
            "id": "4596757",
            "type": "article",
            "attributes": {
                "publishOn": "2023-04-26T12:54:41-04:00",
                "isLockedPro": false,
                "commentCount": 20,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: This Cash-Rich, Predictable Business Should Fare Well Even In A Potential Recession",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "101928",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "452227",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4596757-cvs-health-this-cash-rich-predictable-business-should-fare-well-even-in-a-potential-recession"
            }
        },
        {
            "id": "4593369",
            "type": "article",
            "attributes": {
                "publishOn": "2023-04-11T08:05:00-04:00",
                "isLockedPro": false,
                "commentCount": 41,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1257405518/image_1257405518.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Seriously Undervalued, And I'm Buying More",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105703",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "449135",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4593369-cvs-health-seriously-undervalued-buying-more"
            }
        },
        {
            "id": "4592967",
            "type": "article",
            "attributes": {
                "publishOn": "2023-04-08T10:26:39-04:00",
                "isLockedPro": false,
                "commentCount": 87,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/471569977/image_471569977.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Walgreens Vs. CVS: If Peter Lynch Picked Dividend Stocks",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106207",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "448594",
                            "type": "sentiment"
                        },
                        {
                            "id": "448595",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4592967-walgreens-vs-cvs-if-peter-lynch-picked-dividend-stocks"
            }
        },
        {
            "id": "4591557",
            "type": "article",
            "attributes": {
                "publishOn": "2023-03-31T13:56:57-04:00",
                "isLockedPro": false,
                "commentCount": 30,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/579427534/image_579427534.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS And Oak Street: The Pros And Cons Of A Deal That Felt Inevitable",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104985",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "447385",
                            "type": "sentiment"
                        },
                        {
                            "id": "447386",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4591557-cvs-oak-street-pros-cons-of-deal"
            }
        },
        {
            "id": "4589538",
            "type": "article",
            "attributes": {
                "publishOn": "2023-03-23T14:00:00-04:00",
                "isLockedPro": false,
                "commentCount": 42,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "3.25% Yield And Healthcare Repositioning For CVS Health",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106554",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "445620",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4589538-3-25-percent-yield-and-healthcare-repositioning-for-cvs-health"
            }
        },
        {
            "id": "4587931",
            "type": "article",
            "attributes": {
                "publishOn": "2023-03-16T12:02:24-04:00",
                "isLockedPro": false,
                "commentCount": 51,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1369987284/image_1369987284.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Attractive Value, 3.2% Yield With 10% Recent Dividend Growth",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "91485",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "444271",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4587931-cvs-health-attractive-value-3-2-percent-yield-10-percent-recent-dividend-growth"
            }
        },
        {
            "id": "4587613",
            "type": "article",
            "attributes": {
                "publishOn": "2023-03-15T12:27:12-04:00",
                "isLockedPro": false,
                "commentCount": 52,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1434361859/image_1434361859.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health: Oak Street Acquisition Is A Good Strategic Fit",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106827",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "443821",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4587613-cvs-health-oak-street-acquisition-good-strategic-fit"
            }
        },
        {
            "id": "4586941",
            "type": "article",
            "attributes": {
                "publishOn": "2023-03-13T07:24:42-04:00",
                "isLockedPro": false,
                "commentCount": 85,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS: Explaining Its Extraordinary 13.6% FCF Yield And Why It's A Buy",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106939",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "443430",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/4586941-cvs-explaining-extraordinary-fcf-yield"
            }
        },
        {
            "id": "4584729",
            "type": "article",
            "attributes": {
                "publishOn": "2023-03-05T22:39:27-05:00",
                "isLockedPro": false,
                "commentCount": 13,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/624114992/image_624114992.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Corporation: Stable Long-Term Hold",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106943",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "440606",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4584729-cvs-health-stock-stable-long-term-hold"
            }
        },
        {
            "id": "4577269",
            "type": "article",
            "attributes": {
                "publishOn": "2023-02-10T09:50:34-05:00",
                "isLockedPro": false,
                "commentCount": 54,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/595358808/image_595358808.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Earnings And 2023 Outlook: Bearish On Oak Street Buyout",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "104985",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "437079",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4577269-cvs-health-earnings-review-2023-outlook-bearish-oak-street-buyout"
            }
        },
        {
            "id": "4576749",
            "type": "article",
            "attributes": {
                "publishOn": "2023-02-09T09:35:05-05:00",
                "isLockedPro": false,
                "commentCount": 30,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1269594016/image_1269594016.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Stop Playing Short Term With CVS",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "90115",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "436693",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4576749-cvs-q4-earnings-stop-playing-short-term"
            }
        },
        {
            "id": "4575422",
            "type": "article",
            "attributes": {
                "publishOn": "2023-02-05T03:37:21-05:00",
                "isLockedPro": false,
                "commentCount": 15,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Should Have No Problem Delivering 10% EPS Growth",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105192",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "435720",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4575422-cvs-should-have-no-problem-delivering-10-percent-eps-growth"
            }
        },
        {
            "id": "4570642",
            "type": "article",
            "attributes": {
                "publishOn": "2023-01-19T16:00:00-05:00",
                "isLockedPro": false,
                "commentCount": 35,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/484016185/image_484016185.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Is CVS Making The Same Mistake As Teladoc?",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "106485",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "431713",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4570642-is-cvs-making-the-same-mistake-as-teladoc"
            }
        },
        {
            "id": "4570196",
            "type": "article",
            "attributes": {
                "publishOn": "2023-01-16T09:45:57-05:00",
                "isLockedPro": false,
                "commentCount": 25,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1340094798/image_1340094798.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Oak Street Health And CVS Health: Potential Strategic Merger",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "62233",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "431682",
                            "type": "sentiment"
                        },
                        {
                            "id": "431683",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4570196-oak-street-health-cvs-health-potential-strategic-merger"
            }
        },
        {
            "id": "4570019",
            "type": "article",
            "attributes": {
                "publishOn": "2023-01-15T03:28:41-05:00",
                "isLockedPro": false,
                "commentCount": 68,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1401250676/image_1401250676.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "CVS Health Is A Buy Near Its 52-Week Low",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "80836",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "431429",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4570019-cvs-health-stock-a-buy-near-52-week-low"
            }
        },
        {
            "id": "4569278",
            "type": "article",
            "attributes": {
                "publishOn": "2023-01-11T12:59:30-05:00",
                "isLockedPro": false,
                "commentCount": 74,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304628896/image_1304628896.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Am I Wrong About CVS?",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "102404",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "430652",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "1212",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4569278-am-i-wrong-about-cvs-health-stock"
            }
        }
    ]
}